Rallybio Corp Finalizes 1-for-8 Reverse Stock Split to Maintain Nasdaq Listing

summarizeSummary

Rallybio Corp will implement a 1-for-8 reverse stock split on February 6, 2026, a crucial move to meet Nasdaq's minimum bid price requirement and prevent delisting.

check_boxKey Events

• Reverse Stock Split Finalized

  Rallybio Corp filed an amendment to its Certificate of Incorporation to effect a 1-for-8 reverse stock split.

• Shareholder Approval

  Stockholders approved the reverse stock split proposal at a Special Meeting held on January 26, 2026, following the DEF 14A filing on January 2, 2026.

• Effective Date

  The reverse stock split will be effective at 12:01 a.m. ET on February 6, 2026, with post-split trading commencing the same day.

• Nasdaq Compliance

  This action is critical for the company to regain compliance with Nasdaq's minimum bid price requirement, as its stock currently trades below $1.

auto_awesomeAnalysis

Rallybio Corp has finalized a 1-for-8 reverse stock split, effective February 6, 2026, following shareholder approval. This action is a critical step for the micro-cap company to regain compliance with Nasdaq's minimum bid price requirement, as its stock currently trades below $1. While reverse splits are often viewed negatively as they reflect a low share price, this move is necessary to avoid potential delisting, which would severely impact liquidity and investor access. Investors should monitor the post-split trading and the company's ability to sustain its share price above the minimum threshold.